The current MSCL market cap is 99.26M. The company's latest EPS is CAD -0.1409 and P/E is -6.25.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.07M | -1.04M | -3.25M | -9.72M | -13.03M |
Net Income | -1.94M | -1.49M | -15.51M | -11.32M | -15.89M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 1.47M | 546k | 12.59M | 6.2M | 44.3M |
Total Liabilities | 807k | 1.3M | 2.1M | 2.83M | 3.62M |
Total Equity | 661k | -750k | 10.48M | 3.37M | 40.67M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -2.24M | -907k | -5.03M | -5.64M | -14.5M |
Investing | -6k | N/A | 1.74M | -3k | -17.54M |
Financing | 3.22M | N/A | 7.45M | 2.78M | 51.03M |
Market Cap | 99.26M |
Price to Earnings Ratio | -6.25 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.5 |
Price to Book Ratio | 2.44 |
Dividend Yield | - |
Shares Outstanding | 112.79M |
Average Volume (1 week) | 295.37k |
Average Volume (1 Month) | 254.1k |
52 Week Change | 41.94% |
52 Week High | 1.32 |
52 Week Low | 0.38 |
Spread (Intraday) | 0.02 (2.27%) |
Company Name | Satellos Bioscience Inc |
Address |
79 wellington street west, 33rd floor toronto, ontario M5K 1N2 |
Website | https://www.satellos.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.